Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

NCT07078929 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Relapse B Acute Lymphoblastic Leukemia
Refactory Childhood Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: CD19-IL7Ra CAR-T cells

Sponsor

Chulalongkorn University

Collaborators

[object Object]